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1. Introduction 
The discovery of antibiotics was one of the greatest achievements of the twentieth century. 
The subsequent introduction of sulphonamides, penicillin and streptomycin, broad 
spectrum bacteriostatic antibiotics, bactericidal antibiotics, synthetic chemicals and highly 
specific narrow spectrum antibiotics to clinical medicine transformed the treatment of 
bacterial diseases (Baldry, 1976). However, due to the excessive and inappropriate use of 
antibiotics there has been a gradual emergence of populations of antibiotic –resistant 
bacteria, which pose a global public health problem (Komolafe, 2003).  
According to the WHO, a resistant microbe is one which is not killed by an antimicrobial 
agent after a standard course of treatment (WHO, 1998). Antibiotic resistance is acquired by 
a natural selection process. Antibiotic use to combat infection, forces bacteria to either adapt 
or die irrespective of the dosage or time span. The surviving bacteria carry the drug 
resistance gene, which can then be transferred either within the species/genus or to other 
unrelated species (Wise, 1998). Clinical resistance is a complex phenomenon and its 
manifestation is dependent on the type of bacterium, the site of infection, distribution of 
antibiotic in the body, concentration of the antibiotic at the site of infection and the immune 
status of the patient (Hawkey, 1998). 
Antibiotic resistance is a global problem. While several pathogenic bacteria are resistant to 
first line broad spectrum antibiotics, new resistant strains have resulted from the 
introduction of new drugs (Kunin, 1993, Sack et al, 1997, Rahal et al, 1997, Hoge, 1998).  
Penicillin resistant pneumococci initially isolated in Australia and Papua New Guinea is 
now distributed worldwide (Hansman et al, 1974, Hart and Kariuki, 1998). Similarly, multi-
drug resistant Salmonella typhi was first reported in 1987 and has now been isolated 
throughout the Indian sub-continent, south-east Asia and sub-Saharan Africa. (Mirza et al, 
1996) Komolafe et al (2003) demonstrated a general broad-spectrum resistance to panels of 
antibiotics in 20% of the bacterial isolates of burns patients. Multi –drug resistant 
tuberculosis poses the greatest threat to public health in the new millennium (Kraig, 1998). 
2. Molecular epidemiology of resistance genes 
Antibiotic resistance in bacteria may be intrinsic or acquired. Intrinsic resistance 
mechanisms are naturally occurring traits due to the genetic constitution of the organism. 
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These inherited properties of a particular species are due to lack of either the antimicrobial 
target site or accessibility to the target site (Schwarz et al, 1995). For example, obligate 
anaerobes are resistant to aminoglycosides as they lack the electron transport system 
essential for their uptake (Rasmussen, 1997). Gram –negative organisms are resistant to 
macrolides and certain ß-lactam antibiotics as the drugs are too hydrophobic to traverse the 
outer bacterial membrane (Nikaido, 1989). Acquired resistance is a trait that is observed 
when a bacterium previously sensitive to an antibiotic, displays resistance either by 
mutation or acquisition of DNA or a combination of the two (Tomasz and Munaz, 1995). 
The methods of acquiring antibiotic resistance are as follows: 
 Spontaneous mutations – Spontaneous mutations or growth dependent mutations, that 
occur due to replication errors or incorrect repair of damaged DNA in actively dividing 
cells may be responsible for generating antibiotic resistance (Krasovec and Jerman, 
2003). Point mutations that not only produce antibiotic resistance, but also permit 
growth are attributed to antibiotic resistance (Woodford and Ellington, 2007). For 
example, the quinolone resistance phenotype in Escherichia coli is due to mutations in 
seven positions in the gyrA gene and three positions in the parC gene (Hooper, 1999).  
As a bacterial cell has several targets, access and protection pathways for antibiotics, 
mutations in a variety of genes can result in antibiotic resistance. Studies showed that 
mutations in the genes encoding the targets of rifamicins and fluoroquinolones, i.e. 
RpoB and DNA-topoisomerases respectively, results in resistance to the compounds 
(Martinez and Baquero, 2000; Ruiz, 2003). Adewoye et al (2002) reported that mutation 
in mexR, in P. aeruginosa resulted in upregulation of the mexA-mexB-oprM operon, which 
was associated with resistance to ß-lactams, fluoroquinolones, tetracyclines, 
chloramphenicol and macrolides. Expression of antibiotic uptake and efflux systems 
may be modified by mutations in the regulatory gene sequence or their promoter region 
(Depardieu et al., 2007; Piddock, 2006). Mutations in the E. coli mar gene results in up 
regulation of AcrAB, involved in the efflux of ß-lactams, fluoroquinolones, 
tetracyclines, chloramphenicol from the cell (Barbosa and Levy, 2000). 
 Hypermutation – In the last few years, studies have focussed on the association 
between hypermutation and antibiotic resistance. In the presence of prolonged, non-
lethal antibiotic selective pressure, a small population of bacteria enters a brief state of 
high mutation rate. When a cell in this ‘hyper mutable’ state acquires a mutation that 
relieves the selective pressure, it grows, reproduces and exits the state of high mutation 
rate. While the trigger to enter the hyper mutable state is unclear, it ahs been suggested 
that it is dependent on a special SOS –inducible mutator DNA polymerase (pol) IV 
(Krosovec and Jerman, 2003). Hypermutators have been found in populations of E. coli, 
Salmonella enterica, Neisseria meningitidis, Haemophilus influenzae, Staphylococcus aureus, 
Helicobacter pylori, Streptococcus pneumoniae, P. aeruginosa with frequencies ranging from 
0.1 to above 60% (Denamur et al., 2002; LeClerc et al., 1996). It has been observed that 
the hypermutators isolated from the laboratory as well as from nature have a defective 
mismatch repair system (MMR) due to inactivation of the mutS or mutL genes (Oliver et 
al, 2002). The MMR system eliminates biosynthetic errors in DNA replication, maintains 
structural integrity of the chromosome and prevents recombination between non-
identical DNA sequences (Rayssiguier et al., 1989) Studies have shown that the 
hypermutators play a significant role in the evolution of antibiotic resistance and may 
also be responsible for the multiresistant phenotype (Martinez and Baquero, 2000; 
Giraud et al., 2002; Chopra et al., 2003; Blazquez, 2003, Macia et al., 2005). 
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 Adaptive mutagenesis – Recent studies have demonstrated that in addition to 
spontaneous mutations, mutations occur in non-dividing or slowly dividing cells in the 
presence of non-lethal selective pressure. These mutations, known as adaptive 
mutations, have been associated with the evolution of antibiotic resistant mutants 
under natural conditions (Krasovec and Jerman, 2003; Taddei et al., 1997; Bjedov et al., 
2003). Adaptive mutagenesis is regulated by the stress responsive error prone DNA 
polymerases V (umuCD) and IV (dinB) (Rosche and Foster, 2000; Sutton et al., 2000). 
Piddock and Wise (1997) demonstrated that some antibiotics like quinolones induce a 
SOS mutagenic response and increase the rate of emergence of resistance in E.coli.  
 Horizontal gene transfer – Transfer of genetic material between bacteria, known as 
horizontal gene transfer is responsible fro the spread of antibiotic resistance. Resistance 
genes, consisting of a single or multiple mutations, may be transferred between bacteria 
by conjugation, transformation or transduction, and are incorporated into the recipient 
chromosome by recombination. These genes may also be associated with plasmids 
and/or transposons. Simjee and Gill (1997) demonstrated high level resistance to 
gentamycin and other aminoglycosides (except streptomycin) in enteroccoci. The 
resistance gene was found to be associated with narrow and broad host range plasmids. 
Due to the conjugative nature of the plasmids, spread of the resistance gene to other 
pathogenic bacteria is likely.  
 Horizontal transfer of resistance genes is responsible for the dissemination of multiple 
drug resistance. Gene cassettes are the smallest mobile genetic entities that carry 
distinct resistance determinants for various classes of antibiotics. Integrons are DNA 
elements, located on the bacterial chromosome or on broad host range plasmids, with 
the ability to capture one or more gene cassettes within the same attachment site. 
Movement of the integron facilitates transfer of the cassette-associated resistance genes 
from one DNA replicon to another. When an integron is incorporated into a broad host 
range plasmid, horizontal transfer of the resistance gene may take place. A plasmid 
with a pre-existing resistance gene cassette can acquire additional resistance gene 
cassettes from donor plasmids, thereby resulting in multiresistance integrons (Rowe-
Magnus and Mazel, 1999; Ploy et al., 2000). Over 40 gene cassettes and three distinct 
classes of integrons have been identified (Boucher et al., 2007). Dzidic and Bedekovic 
(2003) investigated the role of horizontal gene transfer in the emergence of multidrug 
resistance in hospital bacteria and demonstrated the transfer of antibiotic resistance 
genes between Gram-positive and Gram negative bacilli from the intestine. The fact that 
bacteria that have been separately evolving for upto 150 million years can exchange 
DNA, has strong implications with regard to the evolution of antibiotic resistance in 
bacterial pathogens (Dzidic et al., 2003; Vulic et al., 1997; Normark and Normark, 2002). 
3. Mechanisms of resistance  
The mechanisms that bacteria exhibit to protect themselves form antibiotic action can be 
classified into the following types. Table 1 gives an overview of representative antibiotics 
and their mechanisms of resistance. 
 Antibiotic inactivation - Inactivation of antibiotic could be a result of either inhibition 
of activation in vivo or due to modification of the parent antibiotic compound, resulting 
in loss of activity. Loss of enzymes involved in drug activation is a relatively new 
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mechanism of drug resistance. Studies have demonstrated that mutations in the nfsA 
and nfsB genes, which encode cellular reductases that reduce members of the nitrofuran 
family (nitrofurantion, nitrofurazone, nitrofurazolidone, etc.), are associated with 
nitrofuran resistance (Kumar and Jayaraman, 1991; Zenno et al., 1996; Whiteway et al., 
1998). 
β-lactamase enzymes cleave the four membered β-lactam ring of antibiotic like 
penicillin and cephalosporin, thereby rendering the antibiotic inactive. The large 
number of β-lactamases identified have been classified based on their structure and 
function. (Bush et al., 1995). The enzymes discovered early (the TEM-1, TEM-2 and 
SHV-1 β-lactamases) were capable of inactivating penicillin but not cephalosporin. 
However, subsequent variants with a variety of amino acid substitutions in and around 
their active sites were identified in many resistant organisms. These have been 
collectively called ‘extended spectrum β-lactamases (ESBLs)’ and act on later generation 
β-lactam antibiotics (Bradford, 2001). 
While most of the ESBLs are derivatives of the early enzymes, newer families of ESBLs, 
like cefotaximases (CTM-X enzymes) and carbapenemases have been discovered 
recently (Bonnet, 2004; Walther-Ramussen, 2004; Canton and Coque, 2006, Livermore 
and Woodford, 2000; Nordman and Poirel, 2002; Queenan and Bush, 2007). The CTM-X 
genes are believed to have descended from progenitor genes present in Klyuvera spp. 
(Decousser et al., 2001; Poirel et al., 2002; Humeniuk et al., 2002). These ESBLs pose a 
significant threat as they provide resistance against a broad antibacterial spectrum 
(Bradford, 2001). 
Enzymatic acetylation of chloramphenicol is the most common mechanism by which 
pathogens acquire resistance to the antibiotic (Schwarz et al., 2004). Mosher et al. (1995) 
established that O-phosphorylation of chloramphenicol affords resistance in 
Streptomyces venezuelae ISP 5230.  
While the resistance to aminoglycosides due to inhibition of drug uptake in Gram 
negative organisms is well documented, aminoglycoside inactivating enzymes have 
been detected in many bacteria and plasmids. The presence of multiple NH2 and OH 
groups enables inactivation of aminglycosides. Inactivation occurs through acylation of 
NH2 groups and either phosphorylation or adenylation of the OH groups. (Azucena 
and Mobashery, 2001) Doi and Arakawa (2007) reported a plasmid-mediated 
mechanism of aminoglycoside resistance involving methylation of 16S ribosomal RNA.  
Fluroquinolones (ciprofloxacin, norfloxacin, ofloxacin) inhibit DNA replication by 
targeting the enzymes, DNA gyrase and topoisomerase IV. Fluoroquinolone resistance 
occurs either through mutations in the genes coding for the subunits of DNA gyrase 
(gyrA and gyrB) and topoisomeraseIV (parC and parE), drug efflux, or a combination of 
both mechanisms. (Levy, 1992; Nikaido, 1996; Li and Nikaido, 2004; Ruiz, 2003; 
Oyamada et al., 2006). However, Robiscek et al (2006) and Park et al (2006) demonstrated 
that a gene encoding an aminoglycoside-specific acetylase could mutate further to give 
an enzyme which could inactivate fluoroquinolones. This is an example to show that 
genes encoding minor and perhaps unrecognized activities, besides the major activity, 
could mutate further to gain extended activity and could be selected by appropriate 
selection pressures. 
Type A and type B streptogramins bind to the 50S ribosomal subunit and inhibit 
translation (Wright, 2007). Resistance to type A streptogramin has been found to be 
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mediated by an enzyme called VatD (virginiamycin acetyl transferase) acetylates the 
antibiotic (Seoane and Garcia-Lobo, 2000; Suganito and Roderick, 2002). Resistance to 
type B streptogramin is brought about by the product of the vgb gene, a C–O lyase 
(Mukhtar et al., 2001). Homologues and orthologues of the genes encoding both the 
enzymes have been detected in a variety of nonpathogenic bacteria, environmental 
bacteria and plasmids (Wright, 2007).  
 Exclusion from the internal environment - Alterations in permeability of the outer 
membrane of bacteria confers antibiotic resistance. This is commonly observed in 
Gram negative bacteria, such as Pseudomonas aeruginosa and Bacteroides fragilis. 
Reports have suggested that the loss or modification of, which are non-specific 
protein channels spanning the outer membrane, have resulted in antibiotic resistance. 
(Nikaido, 1989) 
Activation of efflux pump, which pump out the antibiotics that enter the cells thereby 
preventing intracellular accumulation, is also responsible for antibiotic resistance. 
(Nikaido, 1996; Li and Nikaido, 2004). The AcrAB/TolC system in E. coli is the best 
studied efflux system. The inner membrane protein, Acr B, and outer membrane 
protein, Tol C are linked by the periplasmic protein, Acr A. When activated, the linker 
protein is folds upon itself thereby, bringing the Acr B and Tol C proteins in close 
contact. This results in a channel from inside to the outside of the cell, through which 
antibiotics are pumped out. In antibiotic-sensitive cells, by the product of acrR gene, 
represses the AcrAB/TolC system. A mutation in acrR, causing an arg45cys change, 
activates expression of the system and consequent drug efflux. (Webber et al, 2005). 
Figure 1 shows the AcrAB/TolC efflux system in E.coli.  
 
Fig. 1. Efflux system in E. coli (AcrAB/TolC) system (Pos, 2009) 
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Nine proton-dependent efflux pumps have been identified in E. coli so far. These 
cause the efflux of multiple antibiotics leading to multidrug resistance (Viveiros et al., 
2007). Ruiz (2003) demonstrated that although fluoroquinolone resistance occurred 
commonly due to target mutations, efflux mechanisms were also responsible for the 
phenomenon. 
 Target alteration – Structural changes in the target site of the antibiotic prevent 
interaction of the antibiotic and its target, thus inhibiting the biological activity of the 
antibiotic. This is exemplified by penicillin resistance due to penicillin binding proteins 
(PBPs). PBPs are trans-peptidases which catalyse the crosslinking reaction between two 
peptides each linked to N-acetyl-muramic acid residues of the peptidoglycan backbone 
of the cell wall. Penicillin and other antibiotics which are structurally similar to the 
cross-linked dipeptide forma stable covalent complex with PBPs, inhibit the 
crosslinking reaction, resulting in weakening and lysis of the cell. Mutational changes in 
PBPs, which result in reduction in the affinity of PBPs to penicillin, over expression of 
endogenous, low-affinity PBPs encoding genes result in penicillin resistance (Zapun et 
al., 2008). 
Vancomycin binds non-covalently to the cell-wall precursors of Gram-positive bacteria. 
The binding, which occurs through a set of five hydrogen bonds between the antibiotic 
and the N-acyl-D-ala–D-ala dipeptide portion of the stem pentapeptides linked to the 
N-acetyl muramic acid backbone, blocks the crosslinking transpeptidase reaction 
catalysed by the PBPs. As a result the cell walls are less rigid and more susceptible to 
lysis. In vancomycin-resistant organisms, the stem peptides terminate in D-lactate as 
against D-alanine in the sensitive strains. This eliminates the formation of the crucial 
hydrogen bond and results in a 1000-fold decrease in the affinity for vancomycin and 
consequent resistance to the same. This process is regulated by a two-component 
regulatory system involving a set of five genes (vanR, vanS, vanH, vanA and vanX). 
Enterococci as well as Staphylococcus aureus have been shown to acquire resistance to 
vancomycin by this mechanism, known as vancomycin evasion. (Walsh et al., 1996; 
Arthur et al., 1996; Courvalin, 2006) 
Ruiz (2003) reported that the eight amino acid substitutions in gyrA , which have been 
attributed to fluroquinolone resistance, are predominantly located in the quinolone 
resistance determining region (QRDR). Rifampicin resistance due to mutation in rpoB, 
the gene encoding the ( R )-subunit of RNA polymerase has been observed in rifampicin 
resistant strains of Mycobacterium tuberculosis, laboratory strains of E. coli, other 
pathogens and non pathogens (Jin and Gross, 1988; Anbry-Damon et al., 1998; 
Padayachee and Klugman, 1999; Somoskovi et al., 2001).  
 Production of alternative target – Bacteria may protect themselves from antibiotics, by 
production of an alternative target resistant to inhibition along with the original 
sensitive target. The alternative target circumvents the effect of the antibiotic and 
enables survival of the bacteria. In methicillin resistant Staphylococcus aureus (MRSA) 
alternative penicillin binding protein (PBP2a) is produced in addition to penicillin 
binding protein (PBP). As PBP2a is not inhibited by antibiotics the cell continues to 
synthesise peptidoglycan and has a structurally sound cell wall. It has been suggested 
that the evolution of vancomycin resistant enterococci may lead to transfer of genes to 
S. aureus resulting in vancomycin resistant MRSA (Michel and Gutmann, 1997). 
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Antibiotic Category Examples Mode of action  Major mechanisms of 
resistance 
ß-lactams Penicillin, 
Cephalosporin, 
Cetoximes, 
Carbapenems 
Inhibition of cell 
wall synthesis 
Cleavage by ß-
lactamases, ESBLs, 
CTX-mases, 
Carbapenemases, 
altered PBPs 
Aminoglycosides Streptomycin, 
Gentamycin, 
Tobramycin, 
Amikacin 
Inhibition of protein 
synthesis 
Enzymatic 
modification, efflux, 
ribosomal mutations, 
16S rRNA 
methylation 
Quinolones Ciprofloxacin, 
Ofloxacin, 
Norfloxacin 
Inhibition of DNA Efflux, modification, 
target mutations 
Glycopeptides Vancomycin Inhibition of cell 
wall synthesis 
Altered cell walls, 
efflux 
Tetracyclines Tetracycline Inhibition of 
translation 
Efflux 
Rifamycins Rifampicin Inhibition of 
transcription 
Altered ß-subunit of 
RNA polymerase 
Streptogramins Virginamycins, 
Quinupristin, 
Dalfoprisitin 
Inhibition of cell 
wall synthesis 
Enzymatic cleavage, 
modification, efflux 
Oxazolidinones Linezolid Inhibition of 
formation of 70S 
ribosomal complex 
Mutations in 23 S 
rRNA genes follwed 
by gene conversion. 
Table 1. Representative antibiotics and their mechanisms of resistance. Adapted from 
Jayaraman, 2009 
4. Conclusion 
Emergence of antibiotic resistance is driven by repeated exposure of bacteria to antibiotics 
and access of bacteria to a large antimicrobial resistance pool. Pathogenic and non-
pathogenic bacteria are becoming increasingly resistant to conventional antibiotics. While 
initial studies on antibiotic resistance investigated methicillin resistant Staphylococcus aureus 
and vancomycin resistant Enterococcus spp., the focus has now shifted to multi drug resistant 
Gram –negative bacteria. The emergence of Gram negative Enterobacteriaceae resistant to 
carbapenem due to New Delhi metallo – ß –lactamase 1 (NDM-1) has been identified as a 
major global health problem. (Kumarasamy et al, 2010). However, it must be noted that 
resistance selected in non pathogenic or commensal bacteria could act as a reservoir of 
resistance genes, resulting in emergence of resistance in pathogens. There is a need to 
review the use and check the misuse of antibiotics and to adopt good infection control 
practices in order to control antibacterial resistance, since increasing antibiotic resistance has 
the potential to transport clinical medicine to the pre-antibiotic era. 
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